| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Lanosterol 14-alpha demethylase |
|---|
| Ligand | BDBM22319 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_470779 (CHEMBL934981) |
|---|
| IC50 | >200000±n/a nM |
|---|
| Citation |  Ekins, S; Mankowski, DC; Hoover, DJ; Lawton, MP; Treadway, JL; Harwood, HJ Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. Drug Metab Dispos35:493-500 (2007) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Lanosterol 14-alpha demethylase |
|---|
| Name: | Lanosterol 14-alpha demethylase |
|---|
| Synonyms: | CP51A_HUMAN | CYP51 | CYP51A1 | CYPLI | Cytochrome P450 51 | Cytochrome P450 51A1 | LDM | Lanosterol 14-alpha demethylase | P450-14DM | P45014DM | P450LI | Sterol 14α-demethylase (CYP51) | Sterol 14-alpha demethylase |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 56817.21 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q16850 |
|---|
| Residue: | 503 |
|---|
| Sequence: | MLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKS
PPYIFSPIPFLGHAIAFGKSPIEFLENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNS
KNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSIIEKETK
EYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWL
LPGWLPLPSFRRRDRAHREIKDIFYKAIQKRRQSQEKIDDILQTLLDATYKDGRPLTDDE
VAGMLIGLLLAGQHTSSTTSAWMGFFLARDKTLQKKCYLEQKTVCGENLPPLTYDQLKDL
NLLDRCIKETLRLRPPIMIMMRMARTPQTVAGYTIPPGHQVCVSPTVNQRLKDSWVERLD
FNPDRYLQDNPASGEKFAYVPFGAGRHRCIGENFAYVQIKTIWSTMLRLYEFDLIDGYFP
TVNYTTMIHTPENPVIRYKRRSK
|
|
|
|---|
| BDBM22319 |
|---|
| n/a |
|---|
| Name | BDBM22319 |
|---|
| Synonyms: | (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid | Arachidonic acid | Arachidonic acid (AA) | CHEMBL15594 | [1-14C]Arachidonic acid |
|---|
| Type | Unsaturated fatty acid |
|---|
| Emp. Form. | C20H32O2 |
|---|
| Mol. Mass. | 304.4669 |
|---|
| SMILES | CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O |
|---|
| Structure | 
|
|---|
Search and Browse
